000 01563 a2200481 4500
005 20250513193456.0
264 0 _c19991110
008 199911s 0 0 eng d
022 _a1043-0342
024 7 _a10.1089/10430349950016924
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFan, L
245 0 0 _aImproved artificial death switches based on caspases and FADD.
_h[electronic resource]
260 _bHuman gene therapy
_cSep 1999
300 _a2273-85 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdaptor Proteins, Signal Transducing
650 0 4 _aApoptosis
650 0 4 _aBlotting, Western
650 0 4 _aCarrier Proteins
_xchemistry
650 0 4 _aCaspase 1
_xchemistry
650 0 4 _aCaspase 3
650 0 4 _aCaspase 8
650 0 4 _aCaspase 9
650 0 4 _aCaspases
_xchemistry
650 0 4 _aCell Line
650 0 4 _aCell Membrane
_xchemistry
650 0 4 _aCross-Linking Reagents
_xpharmacology
650 0 4 _aDimerization
650 0 4 _aEnzyme Activation
650 0 4 _aFas-Associated Death Domain Protein
650 0 4 _aFluorescent Antibody Technique
650 0 4 _aHumans
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aTacrolimus
_xanalogs & derivatives
650 0 4 _aTransfection
700 1 _aFreeman, K W
700 1 _aKhan, T
700 1 _aPham, E
700 1 _aSpencer, D M
773 0 _tHuman gene therapy
_gvol. 10
_gno. 14
_gp. 2273-85
856 4 0 _uhttps://doi.org/10.1089/10430349950016924
_zAvailable from publisher's website
999 _c10472504
_d10472504